Lonza’s new drug product manufacturing line in Switzerland goes live 30-Mar-2023 By Jane Byrne Swiss CDMO Lonza has increased capacity and capabilities at its Visp, Switzerland site, with the completion of a new line for cGMP clinical and commercial drug product manufacturing.